Forte Biosciences (FBRX) Insider Trading
Officer, director, and 10%+ owner transactions reported to the SEC on Form 4, with buy/sell totals and cluster activity for Forte Biosciences.
Bought (12 mo)
$254,833
Sold (12 mo)
$0
Insiders Buying (12 mo)
1
Insiders Selling (12 mo)
0
Form 4 Filings (All Time)
122
Most Recent Purchase
January 2, 2026
Antony A Riley
CFO
$254,833
Most Recent Sale
September 8, 2021
Paul A. Wagner
CEO
$4,347,100
Buys (90d)
0
Sells (90d)
0
Recent Insider Transactions
| Filed | Insider | Role | Type | Value | % Change |
|---|---|---|---|---|---|
| 2026-08-27 | Kapoor Shivpreet Singh | Director | Other | — | — |
| 2026-08-27 | Wagner Paul A. | Officer | Other | — | -100.0% |
| 2026-08-27 | Finck Barbara K | Director | Other | — | — |
| 2026-08-27 | Gryska David W | Director | Other | — | -100.0% |
| 2026-08-27 | Riley Antony A | CFO | Other | — | -100.0% |
| 2026-08-27 | Doberstein Stephen K | Director | Other | — | — |
| 2026-08-27 | Brun Scott C. | Director | Other | — | — |
| 2026-08-27 | Kornfeld Steven | Director | Other | — | -100.0% |
| 2026-08-27 | Vincent Richard G | Director | Other | — | — |
Sign up free to view more insider trades.